Zeon Lifesciences Advances U.S. Nutraceutical Readiness
New Delhi, India & New York, United States, August 19, 2026 Zeon Lifesciences, an India-based nutraceutical manufacturer, has strengthened...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
New Delhi, India & New York, United States, August 19, 2026 Zeon Lifesciences, an India-based nutraceutical manufacturer, has strengthened...
TORONTO, April 23, 2026 Apotex Inc. and Cumberland Pharmaceuticals Inc. announced a strategic transaction to integrate Cumberland’s U.S. branded...
Mumbai, India & Naples, Florida | April 10, 2026 Lupin Limited has announced the U.S. launch of Dapagliflozin Tablets...
FORT LEE, N.J., October 9, 2025 — Kedrion Biopharma today announced the U.S. commercial launch of YIMMUGO® (Immune Globulin...
